Stacey Boyer

Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database

Elizabeth D. Bacci, Dorota Staniewska, Karin S. Coyne et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2015 · 38 citations

Education, Neurology, Neuroscience +17

Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia

David P. Walling, Anindita Banerjee, Vikas Kumar Dawra et al. · Journal of Clinical Psychopharmacology · 2019 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Poster #212 RESULTS OF A PHASE 2A PROOF-OF-CONCEPT TRIAL WITH A PDE10A INHIBITOR IN THE TREATMENT OF ACUTE EXACERBATION OF SCHIZOPHRENIA

Nicholas DeMartinis, Anindita Banerjee, Vikas Kumar et al. · Schizophrenia Research · 2012 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +5

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and Digital Biomarker Selection

Spyros Papapetropoulos, Margaret Lee, Stacey Boyer et al. · Frontiers in Neurology · 2019 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Augmentation of a Nicotinic Acetylcholine Receptor Partial Agonist in Depression

Maurizio Fava, Tanya Ramey, Eve H. Pickering et al. · Journal of Clinical Psychopharmacology · 2014 · 17 citations

Pharmacy, Pharmacology, Pharmacotherapy +16